Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial
Launched by UNIVERSITY COLLEGE OF NORTHERN DENMARK · Jun 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a new home-based stretching program can help reduce symptoms in people with fibromyalgia. Fibromyalgia is a condition that can cause widespread pain, fatigue, and other discomforts. The trial will last for six weeks and will compare the effects of this stretching program to the usual care that patients currently receive. By participating, you may help researchers understand if this simple exercise can improve the quality of life for those living with fibromyalgia.
To be eligible for the trial, participants need to be diagnosed with fibromyalgia or related chronic pain conditions based on specific guidelines. If you are between the ages of 18 and 65 and do not have other serious health issues that could interfere with the study, you might qualify. If you join, you can expect to follow the stretching program at home while keeping in touch with the research team to share your experiences. This study is currently recruiting participants, so if you or someone you know is interested, it could be a great opportunity to contribute to important research on fibromyalgia treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals diagnosed with fibromyalgia in accordance with the ACR 2016 diagnostic criteria.
- • individuals diagnosed with chronic non-malignant pain or individuals diagnosed with chronic widespread pain (including fibromyalgia syndrome) are also included when they meet the ACR 2016 diagnostic criteria.
- Exclusion Criteria:
- • Non-controlled systemic disorders (such as hypertension, diabetes and coronary insufficiency),
- • neurological conditions that impair alertness or comprehension, musculoskeletal conditions that could compromise assessments (such as nerve root compression or knee joint inflammation),
- • relevant joint disorders (such as severe arthritis, arthroplasty of the hip or knee, and rheumatoid arthritis),
- • recent changes in therapy for fibromyalgia (i.e., within four weeks of baseline).
About University College Of Northern Denmark
The University College of Northern Denmark (UCN) is a leading educational institution dedicated to advancing health sciences and clinical research. As a sponsor of clinical trials, UCN emphasizes innovation and collaboration, leveraging its academic expertise and state-of-the-art facilities to conduct rigorous research that contributes to evidence-based practices in healthcare. UCN is committed to enhancing patient outcomes and fostering the development of future healthcare professionals through its comprehensive training programs and research initiatives, ensuring a strong alignment between education, clinical practice, and scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, , Denmark
Patients applied
Trial Officials
Lise Eckardt, Pt. Msc
Study Director
Department of Physiotherapy, University College of Northern Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported